2024-10-20 - Analysis Report
## Abbott Laboratories (ABT) Stock Analysis

**Company Overview:** Abbott Laboratories is a global healthcare company that develops, manufactures, and sells a wide range of medical devices, diagnostics, pharmaceuticals, and nutritional products.

**1. Performance vs. S&P 500:**

* **Cumulative Return:** ABT has returned 113.76%, while the S&P 500 (VOO) has returned 137.88%. 
* **Relative Lag:** ABT currently lags behind the S&P 500 by -24.12%. This represents a relative lag of 17.29% compared to the historical range of performance differences between ABT and the S&P 500. 

**2. Recent Price Movement:**

* **Closing Price:** $119.39
* **5-Day Moving Average:** $117.68
* **20-Day Moving Average:** $114.85
* **60-Day Moving Average:** $112.91
* **Interpretation:** The stock is currently trading above all its moving averages, suggesting potential upward momentum in the short term.

**3. Technical Indicators:**

* **RSI:** 72.95 - The stock is considered overbought, indicating potential for a short-term correction.
* **PPO:** 0.38 - This suggests potential for continued bullish momentum.
* **Delta_Previous_Relative_Divergence:** 3.39 - This indicates a recent short-term upward trend in the relative strength of ABT compared to the S&P 500.
* **Expected Return:** 0.0% -  Over the long term (2 years or more), ABT is expected to generate a similar return to the S&P 500, based on current market conditions.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue | 
|---|---|---|
| 2024-07-31 | 0.74 | 10.38 B$ | 
| 2024-05-02 | 0.7 | 9.96 B$ |
| 2023-11-01 | 0.82 | 10.14 B$ | 
| 2023-08-03 | 0.79 | 9.98 B$ |
| 2024-07-31 | 0.79 | 9.98 B$ | 

* **Analysis:**  Abbott Laboratories' earnings have been relatively stable over the past few quarters. While revenue has experienced some fluctuations, it generally shows a trend of growth. The latest quarter's earnings have been slightly below analysts' expectations, however, the company remains a strong player in the healthcare industry with continued growth potential. 

**5. News and Recent Issues:**

* **Recent Market Outlook:**  Abbott Laboratories continues to be a consistent player in the healthcare market, with its various segments including diagnostics, medical devices, and nutrition.  Analysts anticipate steady growth, particularly in the diagnostics sector due to the growing demand for COVID-19 testing.
* **Analyst Opinions:**  Analysts generally have a "Buy" or "Hold" rating for ABT.  The stock is considered a solid investment with a stable dividend and long-term growth potential.
* **Performance Highlights:**  Abbott Laboratories has a strong track record of dividend growth.  The company's consistent profitability and focus on innovation are expected to continue driving future growth.

**6. Overall Analysis:**

Abbott Laboratories is a large-cap healthcare company with a solid track record of performance.  While the stock is currently trading above its moving averages, it is important to note the overbought RSI reading, which suggests a potential for a short-term correction.  Despite this, the company's earnings have remained relatively stable, and analysts anticipate future growth.  For long-term investors, ABT offers a steady dividend and potential for long-term appreciation. 

**7. Recommendation:**

Based on the current market conditions, ABT presents a solid investment opportunity for investors looking for a stable dividend and long-term growth potential in the healthcare sector. However, it is important to monitor the stock's technical indicators, particularly the RSI, for potential short-term corrections. 
